Search Clinical Pathways
Ventilator Weaning Clinical Pathway — PICU
The PICU pathway for ventilator weaning provides guidance on the management and weaning of conventional mechanical ventilation and extubation readiness in intubated patients in the intensive care unit.
Newborn Persistent Hypoglycemia Clinical Pathway — N/IICU
The Persistent Hypoglycemia, Newborn clinical pathway standardizes and describes the initial evaluation and treatment of persistent hypoglycemia in the neonate.
Brief Resolved Unexplained Event Clinical Pathway — Emergency and Inpatient
Emergency Department pathway for infant presenting with a brief, resolved, concerning event.
Diabetic Ketosis without Acidosis Clinical Pathway — Inpatient
This clinical pathway guides the care of the child with diabetes and illness or suspected Ketosis without Acidosis in all hospital inpatient units.
Multisystem Inflammatory Syndrome (MIS-C) Clinical Pathway — Emergency, ICU and Inpatient
Multisystem Inflammatory Syndrome (MIS-C), ED, ICU and Inpatient
Sickle Cell and Acute Chest Syndrome Clinical Pathway — Inpatient
Treatment for the hospitalized Sickle Cell patient with Acute Chest Syndrome.
Bronchiolitis Clinical Pathway — Inpatient
The bronchiolitis pathway details the steps necessary in the assessment and treatment of a child with bronchiolitis in an inpatient setting.
Inhaled Nitric Oxide for Persistent Pulmonary Hypertension Clinical Pathway — N/IICU
The inhaled nitric oxide pathway takes a step-by-step approach to the initiation and management of nitric oxide in newborns with persistent pulmonary hypertension.
COVID-19 Screening Clinical Pathway — Outpatient Specialty Care and Primary Care
The Outpatient Specialty Care and Primary Care Coronavirus Pathway provides guidance for the evaluation and care of patients with laboratory-confirmed 2019-nCoV or who is under investigation for 2019-nCoV while that patient was ill.
COVID-19 Screening Clinical Pathway — Emergency
The ED Coronavirus Pathway provides guidance for the evaluation and care of patients with laboratory-confirmed 2019-nCoV or who is under investigation for 2019-nCoV while that patient was ill.